Skip to main content
. Author manuscript; available in PMC: 2020 Jun 20.
Published in final edited form as: Leukemia. 2019 Dec 20;34(6):1588–1598. doi: 10.1038/s41375-019-0682-7

Figure 5. GS-5829 also targets CLL nurselike cells in CLL/NLC co-cultures.

Figure 5.

(A) The mean (with 95% CI) number of NLC per visual field was calculated in CLL/NLC co-cultures treated with 400 nM GS-5829, 1 μM ibrutinib or both for 120 hours (N=17). (B) Representative microphotographs from one CLL/NLC co-culture (sample 348). Modified Giemsa stain, original magnification ×100. (C) Comparison of the effects of 400 nM GS-5829 or JQ1 on NLC numbers. The mean with 95% CI of normalized cell numbers as measured in 5 samples.